Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Cancer. 2013 Dec 21. doi: 10.1002/ijc.28690. [Epub ahead of print]

Emerging role of nanog in tumorigenesis and cancer stem cells.

Author information

  • 1Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, 43210.

Abstract

Nanog is a transcription factor that is well-established as a key regulator of embryonic stem cell (ESC) maintenance. Recent evidence demonstrates that Nanog is dysregulated and intimately involved in promoting tumorigenesis in part through regulation of the cancer stem cell (CSC) population. Elevated Nanog is associated with poorer outcome in numerous epithelial malignancies. Nanog is enriched in CSCs and ablation of Nanog is sufficient to reduce the CSC pool. Nanog has also been implicated to promote chemoresistance and epithelial-mesenchymal transition (EMT). Insight into the Nanog signaling cascade, upstream regulators and downstream effectors, is beginning to emerge but remains to be fully elucidated. This review highlights the current literature on the emerging role of Nanog in tumorigenesis and CSCs. © 2013 Wiley Periodicals, Inc.

Copyright © 2013 UICC.

KEYWORDS:

Nanog; and epithelial-mesenchymal transition; cancer initiating cells; cancer stem cells; prognostic biomarkers

PMID:
24375318
[PubMed - as supplied by publisher]
PMCID:
PMC4065638
[Available on 2015/6/21]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk